This study is in progress, not accepting new patients
Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)
Summary
- Eligibility
- for people ages 18-80 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- MorphoSys AG
- ID
- NCT04145440
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 30 study participants
- Last Updated